Fed judge orders Purdue Pharma to release sealed case records on what it knew about Oxycontin and how addictive it is

A federal judge has ordered that the maker of Oxycontin, Purdue Pharma release records in a case in which Kentucky alleged that improper marketing of the powerful painkiller fueled a widespread addiction and death. The lawsuit alleged that Purdue misrepresented how easy it is to become addicted to Oxycontin. Purdue Pharma, agreed in December to...
Continue reading…

Wyeth and Pfizer pay $784.6 million over drug overpricing probe whistleblowers to receive $98 million

Pharmaceutical companies Wyeth and Pfizer Inc.will pay $784.6 million to resolve allegations that Wyeth knowingly reported to the government false and fraudulent prices on two of its proton pump inhibitor (PPI) drugs, Protonix Oral and Protonix IV. Pfizer, which is headquartered in New York City, acquired New Jersey-based Wyeth in 2009, approximately three years...
Continue reading…

U.S. probes possible billion dollar scams on pain creams

The Justice Department is investigating half a billion dollars in possible health-care fraud linked to specialty creams used to treat pain which victimized veterans according to a report in the Wall Street Journal. Compounding creams have recently been pitched by retired NFL quarterback Brett Favre, who promoted them to the elderly, athletes and others. It...
Continue reading…

Endo Pharma and Qualitest Pharma pay $39 million to Uncle Sam for under strength flouride tabs for kids

The United States Attorney's Office in New York has announced a $39 million settlement against Vintage Pharmaceuticals, LLC, d/b/aŒ QUALITEST PHARMACEUTICALS; Vintage'S corporate parent Endo Pharmaceuticals, Inc.; and seven of their corporate subsidiaries or affiliates (collectively, "QUALITEST") in a civil fraud lawsuit. This global settlement resolves federal claims under the False Claims Act, 31...
Continue reading…

Why Novartis agreed to pay a whopping $370 million to settle drug kickbacks case

Novartis Pharmaceuticals, maufacturer of Excedrin, Ritalin and other popular drugs, this week agreed to pay $370 million for paying kickbacks to pharmacies to push its drugs on patients. Federal prosecutors said Novartis' scheme involved two drugs, including Exjade, used to reduce iron overload in patients who are receiving long-term blood transfusions. In 2007, sales of...
Continue reading…